ÂÜÀòÂÒÂ×

Dr. Bhargava brings over 5 years of progressively senior positions in strategy, due diligence and advisory in the life sciences industry. Prior to joining Allele, he was a Manager at Pointe Advisory, where he focused extensively on clinical trials in oncology and rare disease. Prior to Pointe Advisory, ​​he worked at Ana Health as Head of Business Development and Medical Director, and as a Founder and Managing Partner at BharCode, a proprietary healthcare application linking medical residents and physicians with home-bound patients.

Dr. Bhargava was a resident physician at Eastern Virginia Medical School and conducted his postdoctoral research at the University of Chicago related to oncological repercussions of inflammatory bowel disease treatment. He earned his Doctorate of Medicine at the University of Windsor School of Medicine, where he finished basic science coursework at top of his class, and earned US Medical Licensing Examination step 1 and 2 scores in the 99th percentile. He also holds a Bachelor of Science in Biology from Indiana University. He serves on Wilmington Capital Securities’ Equity Capital Life Sciences Division and holds FINRA Series 7 and 63 licenses.​​